Document |
Document Title |
WO/2024/039331A1 |
The present invention belongs to bone tissue engineering technical field, relates to a bio-compliant product which is suitable for use in repair and/or treatment of bone breakages and/or bone diseases that are genetic or that occur after...
|
WO/2024/038783A1 |
[Problem] The present invention addresses the problem of developing a stretchable biomaterial (in particular, a stretchable collagen). [Solution] The present inventors: found a method for producing a polyrotaxane comprising a cyclic mole...
|
WO/2024/037952A1 |
The present invention relates to bone cement composites comprising at least one cement base material and biodegradable metallic fibers made of a metal alloy, said fibers comprising at least three chemical elements in the alloy, wherein a...
|
WO/2024/039773A1 |
The cell encapsulation system (CES) device is a device used for dermal, subdermal, muscle, tissue, or organ implantation into an individual (host) that is capable of being loaded with and carrying and containing exogenously introduced ce...
|
WO/2024/034559A1 |
The present invention provides a method for mass producing cell aggregates such as artificial organoids through an approach that differs entirely from previous methods. Specifically, provided is a method for producing cell aggregates tha...
|
WO/2024/035104A1 |
The present invention relates to a cell-DNA hydrogel complex and a method for producing same. In the cell-DNA hydrogel complex of the present invention, cells with a first functional group protruding from the surface thereof and a DNA hy...
|
WO/2024/035964A1 |
Featured are compositions and methods for an ovarian implant comprising ovarian support cells. In particular, the disclosure features methods of culturing ovarian support cells for the purpose of implantation into a subject in need there...
|
WO/2024/032284A1 |
The present invention relates to a sclera reinforcement material, a method for preparing the same and use thereof. The method comprises the following steps: (1) cutting a dermal tissue from an animal skin tissue serving as a raw material...
|
WO/2024/031883A1 |
The present application relates to the technical field of medical application, in particular to the use of cinnamaldehyde and a tissue engineering scaffold. Specifically, the use of cinnamaldehyde is as follows: 1) use in the preparation...
|
WO/2024/035690A1 |
In certain embodiments, the present invention relates to a sustained release, biodegradable drug-delivery system, comprising an organogel and an active agent, the organogel comprising a hydrophobic organic liquid, and a biodegradable, co...
|
WO/2024/033950A1 |
Provided is an implantable tissue scaffold comprising a mixture of a biocompatible organic polymer and chitin, wherein the chitin is embedded in the biocompatible organic polymer. Also provided is a composition for 3D printing, the compo...
|
WO/2024/036108A1 |
Described are devices, systems, and methods for controlled delivery of therapeutic and/or diagnostic agent(s) in a tissue in a subject. In particular, provided are carrier devices in which the agent(s) may be enclosed. One or more carrie...
|
WO/2024/034610A1 |
This frozen and thawed hydrogel comprises a modified polyvinyl alcohol, and a drug. This method for producing a frozen and thawed hydrogel comprises: executing, at least twice, a freezing and thawing cycle in which a composition containi...
|
WO/2024/035684A1 |
The present disclosure provides hair follicle organoids comprising induced dermal papilla (DP) cells and induced epithelial cells, methods of producing or growing hair follicle organoids, and methods for screening a compound for hair gro...
|
WO/2024/034706A1 |
The present invention relates to a peloid-based bioink composition that can be 3D printed without a photo cross-linking agent, the composition containing: 0.1 to 90 parts by weight of a sea silt extract (peloid); 0.1 to 90 parts by weigh...
|
WO/2024/030599A1 |
Technologies for particle scaffold analysis include a computing device that obtains labeled input data indicative of particles positioned in a scaffold domain. The input data may be generated by an imaging system coupled to the computing...
|
WO/2024/029412A1 |
Provided is a silica-(calcium phosphate) composite block body which has high strength and cannot be disintegrated in water and furthermore shows an excellent bone production capability. The silica-(calcium phosphate) composite block body...
|
WO/2024/029594A1 |
A specific silicon compound is represented by the general formula, and the individual symbols are explained in the description. This composition contains the silicon compound indicated above and cetylpyridinium chloride hydrate, and assu...
|
WO/2024/027650A1 |
Provided are a bone cement material containing a starch component and a method for preparing same. The bone cement has higher mechanical strength and a curing time more suitable for surgical operations. The bone cement exhibits good inje...
|
WO/2024/030661A1 |
Shape-restoring materials, as well as techniques for generating shape-restoring materials, are described. An example method includes generating a construct by exposing, to UV-visible light, a resin comprising a globular protein, a water-...
|
WO/2024/028882A1 |
The invention related to an implant comprising a scaffold comprising at least one first area characterized by micropores and at least one second area characterized by macropores, wherein said at least one second area is defined by being ...
|
WO/2024/029246A1 |
The present invention provides an absorbent article that contains a water absorbent resin having excellent water absorption performance. The present invention relates to an absorbent article that contains a water absorbent resin comprisi...
|
WO/2024/027195A1 |
Disclosed are a method for processing a biofilm material, the biofilm material and an artificial biovalve. The method for processing the biofilm material comprises: pretreating a biofilm, such that the biofilm has loaded thereon a first ...
|
WO/2024/030186A1 |
The present disclosure provides compositions comprising a microgel scaffold formed by polyethylene glycol-vinyl sulfone (PEG-VS) and polyethylene glycol-dithiol (PEG-DT), as well as methods of making thereof.
|
WO/2024/030521A1 |
Provided herein is a copper-free, non-toxic click hydrogel that exhibits minimal swelling and derived from dibenzocyclooctyne maleimide, poly-ethylene glycol dithiol and azide acrylate. The hydrogel may be used as a sealant and/or as a d...
|
WO/2024/028241A1 |
The invention relates to a nonwoven fabric (2), to an implant (1) comprising a nonwoven fabric (2), and to a method for producing such a nonwoven fabric (2). The aforementioned nonwoven fabric (2) comprises fibers (3) with a fiber struct...
|
WO/2024/030479A1 |
The present invention provides a birth tissue derived implant for treating a subject. The birth tissue derived implant comprises a birth tissue and an agent exogenous to the birth tissue. The birth tissue is isolated from an amniotic sac...
|
WO/2024/026459A1 |
The present invention relates to new implants, especially breast implants, which are bio-durable, biocompatible, which provide a soft tissue feel, and having a reduced density. Said implants comprise a shell and a filling enclosed by the...
|
WO/2024/024708A1 |
The present invention addresses the problem of providing a novel composition for cartilage repair including cells that have characteristics suitable for cartilage repair, and a method for producing same. With a focus on umbilical cord ...
|
WO/2024/025799A1 |
Presented herein are devices, systems, and methods related to liquid infused substrates for use in medical applications. Adhesion of proteins, pathogens, and other substances to medical devices presents an issue. Proteins from the surrou...
|
WO/2024/021869A1 |
Disclosed are an in-vivo rapid recellularization tissue engineered blood vessel and a preparation method therefor. The preparation method comprises: dissolving polyglycolic acid and polyethylene glycol in an organic solvent to prepare a ...
|
WO/2024/025937A2 |
An advanced manufactured interpenetrating polymer network (AM-IPN) comprising: a primary polymer network; a secondary polymer network, wherein the secondary polymer network is bonded to the primary polymer network via one or more crossli...
|
WO/2024/026148A1 |
Provided are stapled peptides and conjugates thereof that have antibacterial activity against microbial pathogens that include, but are not limited to, multidrug-resistant bacteria. Also provided are stapled peptides and conjugates there...
|
WO/2024/020650A1 |
The present invention describes a method of distributing one or more of noble metal and inorganic particles throughout a thermoplastic polymer matrix, the method comprising: providing thermoplastic polymer particles having a nucleated sh...
|
WO/2024/021544A1 |
The present invention provides use of vitamin C lactate and analogs thereof in the preparation of articles of manufacture for skin tissue, and related articles of manufacture thereof. The vitamin C lactate and the analogs thereof of the ...
|
WO/2024/022079A1 |
A use of a human mesenchymal stem cell sheet in the preparation of a drug for treating uterine scars, and a use of a human mesenchymal stem cell sheet in the preparation of a composition for treating a uterine scar in a subject. The huma...
|
WO/2024/020635A1 |
The present disclosure relates to hydrogels, and in particular, extracellular matrix hydrogels obtained from decellularised tissue. In some examples, the extracellular matrix hydrogel is obtaind from healthy endometrial tissue. The hydro...
|
WO/2024/023688A1 |
The invention relates to an anti-microbial gelatin-methacryloyl (GelMA) hydrogel nanocomposite comprising capped silver nanoparticles (AgNP). The nanocomposite hydrogel can be combined with bone graft material to form a bone graft constr...
|
WO/2024/025808A1 |
Disclosed are improved methods of making liver organoids, and methods of making population organoid panels which can be used, for example, for genotype-pheontype analysis or screening of test compounds. Also disclosed are methods of asse...
|
WO/2024/022890A1 |
The invention relates to a muscle membrane intended to be affixed to a muscle of a human or animal body, the membrane being capable of at least partially surrounding the muscle, the muscle comprising fibres covered with an outer tissue, ...
|
WO/2024/023350A1 |
The present disclosure relates to a hydrogel composition based on anionic cyclodextrin polymers and chitosan for use in the treatment of articular disorders. In particular, the hydrogel combines a pharmacological action, in particular an...
|
WO/2024/019245A1 |
The present invention relates to an intraocular lens using a Moiré interference hydrogel. The Moiré intraocular lens according to the present invention makes it possible to easily detect the presence of and quantitatively detect a targ...
|
WO/2024/019605A1 |
The present invention relates to a scan body or abutment for implants, comprising a coating layer which reduces surface reflectance and increases biocompatibility, wherein the surface reflectance is reduced, and thus, highly accurate sca...
|
WO/2024/016481A1 |
Disclosed is a charged composite film material with high osteogenic activity, a method for preparing same, and use thereof. The charged composite film with high osteogenic activity provided by the present invention consists of an inorgan...
|
WO/2024/016740A1 |
Provided is a biosynthesis-based preparation method for a structural material of the human body. A polypeptide of the present application contains the structure of a C-terminal region of (repeating unit)n or (repeating unit)n-; the repea...
|
WO/2024/020558A1 |
Described herein is a hydrogel including a hydrogel polymer; a crosslinker crosslinking the hydrogel polymer; a biomolecule attached to the hydrogel polymer; and water. In the hydrogel, the biomolecule is attached to the hydrogel polymer...
|
WO/2024/019344A1 |
The present invention provides a selective apatite film forming method using a laser and a selective apatite film forming apparatus, the selective apatite film forming method comprising the steps of: (a) immersing an implant substrate in...
|
WO/2024/020475A1 |
The present disclosure provides photocurable hydrogel compositions and methods of using in the treatment of tympanic membrane perforations.
|
WO/2024/018136A1 |
Collagen-based tissue matrices (2) are treated in a reactor (1) with a flow of supercritical carbon dioxide, including at least one chemical additive inserted via an insertion device (P2, V12) in communication with a loop (20). The addit...
|
WO/2024/019673A1 |
The invention relates to a chemical formulation coating to be applied to health apparatus and products such as injectors, especially nasogastric tubes (NGT) to be used in the medical field, in other words to areas where antibacterial/ant...
|